Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)GlobeNewsWire • 01/16/24
Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023GlobeNewsWire • 12/22/23
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZenecaGlobeNewsWire • 11/15/23
Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023GlobeNewsWire • 11/06/23
Cellectis to Present Preliminary Results of NATHALI_01 and Updated Results of the BALLI_01 Phases I Trials at the American Society of Hematology (ASH) 65th Annual MeetingGlobeNewsWire • 11/02/23
Cellectis' stock is the biggest gainer and most active premarket after equity investment, collaboration pact with AstraZenecaMarket Watch • 11/01/23
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZenecaGlobeNewsWire • 11/01/23
Cellectis Presents Pre-Clinical Data on Multi-armored Allogeneic MUC1-CAR T-cells Targeting Triple-Negative Breast Cancer at the Society for Immunotherapy of Cancer (SITC) 38th Annual MeetingGlobeNewsWire • 10/31/23
Cellectis to Present Pre-Clinical Data on HSPC Gene Therapy Program and Comprehensive Analysis of TALE-BE at the ESGCT 30th Annual CongressGlobeNewsWire • 10/24/23
Cellectis and Imagine Institute Publish A Proof-Of-Concept Study of a Gene Surgery Candidate to Treat Activated Phosphoinositide 3-Kinase Δ Syndrome Type 1 (APDS1)GlobeNewsWire • 10/12/23
Cellectis to Present Pre-Clinical Data on Multi-armored Allogeneic MUC1-CAR T-cells Targeting Triple-Negative Breast Cancer at the Society for Immunotherapy of Cancer (SITC) 38th Annual MeetingGlobeNewsWire • 09/27/23
Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023GlobeNewsWire • 08/03/23
Cellectis S.A. Reports Results from Annual Shareholders' General Meeting Held on June 27, 2023GlobeNewsWire • 06/28/23
Cellectis Presents Updated Clinical and Translational Data on BALLI-01 at the European Hematology Association (EHA) 2023GlobeNewsWire • 06/09/23